Martina Wiedau-Pazos

Title: Martina Wiedau-Pazos: Innovator in ALS Research

Introduction

Martina Wiedau-Pazos is a prominent inventor based in Los Angeles, CA, known for her significant contributions to the field of amyotrophic lateral sclerosis (ALS) research. Her innovative work focuses on understanding the mechanisms of radical formation associated with mutant CuZnSOD enzymes, which are linked to familial amyotrophic lateral sclerosis.

Latest Patents

Martina holds a patent for a method of modulating radical formation by mutant CuZnSOD enzymes. This patent addresses the discovery that familial amyotrophic lateral sclerosis-associated mutant CuZnSODs, specifically A4V and G93A, catalyze the generation of hydroxyl radicals from hydrogen peroxide at rates higher than that of the wild type CuZnSOD. The research indicates that the copper chelator diethyldithiocarbamate (DDC) can inhibit both radical generation and SOD activity of these mutant enzymes at significantly lower concentrations than required for the wild type. In neural cell culture models of FALS, DDC has been shown to reverse the effects of four FALS-associated mutants without altering the survival of cells expressing only the wild type CuZnSOD. This suggests that radical formation can be modulated, offering potential treatment avenues for ALS through the administration of copper chelating agents and radical scavenging agents.

Career Highlights

Throughout her career, Martina has worked with esteemed institutions such as the Burnham Institute and the University of California. Her research has significantly advanced the understanding of ALS and the role of mutant enzymes in radical formation.

Collaborations

Martina has collaborated with notable scientists, including Joan S. Valentine and Edith B. Gralla, contributing to a rich exchange of ideas and research findings in the field of ALS.

Conclusion

Martina Wiedau-Pazos is a trailblazer in ALS research, with her innovative patent and collaborative efforts paving the way for potential treatments. Her work exemplifies the impact of scientific innovation on understanding and addressing complex diseases.